Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Buprenorphine cost?

See the DrugPatentWatch profile for Buprenorphine

The cost of buprenorphine can vary significantly based on several factors, including the specific formulation, dosage, insurance coverage, and pharmacy. Buprenorphine is available in various forms, such as sublingual tablets, films, and injections, each with different pricing.

How much does buprenorphine typically cost?


Without insurance, the cost of buprenorphine can range from approximately $100 to over $400 for a month's supply. For example, generic buprenorphine sublingual tablets might cost around $100-$200 for a 30-day supply, while brand-name formulations or newer injectable versions can be considerably more expensive, sometimes exceeding $400 per month. These prices are estimates and can fluctuate [1].

How does insurance affect buprenorphine prices?


Insurance plans can substantially lower out-of-pocket costs for buprenorphine. Many insurance providers cover buprenorphine, especially for medically supervised treatment of opioid use disorder. The actual cost to a patient with insurance will depend on their specific plan's copay, deductible, and formulary. Some plans may require prior authorization or have preferred generic options to manage costs [1].

What is the difference in cost between buprenorphine formulations?


Different formulations of buprenorphine have distinct price points. Generic sublingual tablets are generally the most affordable option. Buprenorphine/naloxone films (like Suboxone) can be more expensive than tablets. Newer injectable formulations, such as those approved for longer-acting treatment, often come with a higher price tag due to their advanced delivery mechanism and longer duration of action [1].

When does buprenorphine patent exclusivity expire?


The patent exclusivity for buprenorphine products varies by specific formulation and brand. For example, the original patents for buprenorphine sublingual tablets have long since expired, allowing for generic competition. However, newer combination products or extended-release formulations may have later patent expiry dates. Information on specific patent expiries can be tracked through resources like DrugPatentWatch.com [2].

Are there generic options for buprenorphine?


Yes, generic versions of buprenorphine, particularly the sublingual tablets, are widely available. The availability of generics has helped to reduce the cost of buprenorphine for many patients, making treatment more accessible [1].

What factors influence buprenorphine pricing beyond generics?


Pricing can also be influenced by market demand, manufacturing costs, and the specific indications for which the drug is prescribed. Buprenorphine is used both for opioid use disorder treatment and pain management, and pricing strategies may differ based on these applications [1].

How does buprenorphine compare to other opioid use disorder treatments in terms of cost?


When compared to other medications for opioid use disorder, such as methadone or naltrexone, buprenorphine's cost can be competitive, especially with generic availability. However, the overall cost of treatment also includes clinical services, counseling, and monitoring, which are integral to managing opioid use disorder [1].

Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com



Other Questions About Buprenorphine :

Buprenorphine manufacturers? Buprenorphine vs heroin? Buprenorphine original patent date? Generic Buprenorphine Inconsistencies Causing Weird Side Effects?